Hepatitis B virus preS2Δ38–55 variants: A newly identified risk factor for hepatocellular carcinoma

Damien Cohen (1) , Sumantra Ghosh (1) , Yusuke Shimakawa (2) , Njie Ramou (3) , Pierre Simon Garcia (4) , Anaëlle Dubois (1) , Clément Guillot (1) , Nora Kakwata-Nkor Deluce (1) , Valentin Tilloy (5) , Geoffroy Durand (3) , Catherine Voegele (3) , Gibril Ndow (6) , Umberto d'Alessandro (6) , Celine Brochier-Armanet (4) , Sophie Alain (5) , Florence Le Calvez-Kelm (3) , Janet Hall (4) , Fabien Zoulim (1, 7) , Maimuna Mendy (3) , Mark Thursz (8) , Maud Lemoine (8) , Isabelle Chemin (1)

1 UNICANCER/CRCL - Centre de Recherche en Cancérologie de Lyon
2 Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology
3 CIRC - IARC - Centre International de Recherche contre le Cancer - International Agency for Research on Cancer
4 LBBE - Laboratoire de Biométrie et Biologie Evolutive - UMR 5558
5 Hôpital Dupuytren [CHU Limoges]
6 London School of Hygiene and Tropical Medicine [Fajara, Gambia]
7 HCL - Hospices Civils de Lyon
8 Imperial College London

Domains: Life Sciences [q-bio]; Santé publique et épidémiologie

Damien Cohen, Sumantra Ghosh, Yusuke Shimakawa, Njie Ramou, Pierre Simon Garcia, et al.. Hepatitis B virus preS2Δ38–55 variants: A newly identified risk factor for hepatocellular carcinoma. JHEP Reports Innovation in Hepatology, 2020, 2 (5), pp.100144. ⟨10.1016/j.jhepr.2020.100144⟩. ⟨pasteur-03697731⟩